Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.8 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |